Bortezomib Consolidation or Maintenance Following Immunochemotherapy and Autologous Stem Cell Transplantation for Mantle Cell Lymphoma: CALGB/Alliance 50403

Immunochemotherapy followed by autologous transplant (ASCT) in CALGB/Alliance 59909 achieved a median progression-free survival (PFS) in mantle cell lymphoma (MCL) of 5 years, but late recurrences occurred. We evaluated tolerability and efficacy of adding post-transplant bortezomib consolidation (BC...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Hematol
Main Authors: Kaplan, Lawrence D., Maurer, Matthew J., Stock, Wendy, Bartlett, Nancy L., Fulton, Noreen, Pettinger, Adam, Byrd, John C., Blum, Kristie A., LaCasce, Ann S., Hsi, Eric D., Liu, Yi Tian, Scott, David W., Hurd, David, Ruppert, Amy S., Hernandez-Ilizaliturri, Francisco, Leonard, John P., Cheson, Bruce. D.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7486983/
https://ncbi.nlm.nih.gov/pubmed/32170769
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.25783
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados